Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients

被引:96
|
作者
Hu, YY
He, SS
Wang, XC
Duan, QH
Khatoon, S
Iqbal, K
Grundke-Iqbal, I
Wang, JZ
机构
[1] New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA
[2] Tongji Med Coll, HUST, Wuhan 430030, Peoples R China
关键词
Alzheimer disease; vascular dementia; neurofilament protein subunits; cerebrospinal fluid; enzyme-linked immunosorbent assay; bienzyme substrate-recycle enzyme-linked immunosorbent assay; biomarkers;
D O I
10.1016/S0304-3940(02)00047-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurofilament (NF) subunits NF-H, NF-M and NF-L are hyperphosphorylated and elevated in Alzheimer disease (AD) brain. We investigated the level and phosphorylation states of NF subunits in lumbar cerebrospinal fluid (CSF) from living patients by bienzyme substrate-recycle enzyme-linked immunosorbent assay. We found: (i), that the levels of phosphorylated NF-H/M (pNF-H/M), non-phosphorylated NF-H/M (npNF-H/M) and NF-L were significantly higher (pNF-H/ M, similar to12-24-fold; npNF-H/M, similar to3-4-fold) in neurologically healthy aged people than young control individuals; (ii), that in AD, the levels of npNF-H/M, and NF-L were similar to vascular dementia (VaD), and higher than in age-matched controls; and (iii), that the levels of pNF-H/M were significantly higher than in aged controls, non-AD neurological disorders and VaD. Based on these findings, it is suggested that the increased level of total NF proteins in CSF could be used as a marker for brain aging and neurodegenerative disorders in general, and the levels of pNF-H/M as a marker to discriminate AD from normal brain aging and as well as neurological conditions including VaD. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:156 / 160
页数:5
相关论文
共 50 条
  • [1] Elevated levels of phosphorylated neurofilament heavy subunit in the cerebrospinal fluid of patients with lumbar spinal stenosis: preliminary findings
    Ohya, Junichi
    Chikuda, Hirotaka
    Kato, So
    Hayakawa, Kentaro
    Oka, Hiroyuki
    Takeshita, Katsushi
    Tanaka, Sakae
    Ogata, Toru
    SPINE JOURNAL, 2015, 15 (07): : 1587 - 1592
  • [2] Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis
    Kaiserova, M.
    Grambalova, Z.
    Otruba, P.
    Stejskal, D.
    Vranova, H. Prikrylova
    Mares, J.
    Mensikova, K.
    Kanovsky, P.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (04): : 360 - 364
  • [3] Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease
    Kosicek, M.
    Zetterberg, H.
    Andreasen, N.
    Peter-Katalinic, J.
    Hecimovic, S.
    NEUROSCIENCE LETTERS, 2012, 516 (02) : 302 - 305
  • [4] Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
    De Schaepdryver, Maxim
    Jeromin, Andreas
    Gille, Benjamin
    Claeys, Kristl G.
    Herbst, Victor
    Brix, Britta
    Van Damme, Philip
    Poesen, Koen
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (04): : 367 - 373
  • [5] Elevated cerebrospinal fluid pressure in patients with Alzheimer's disease
    Silverberg G.
    Mayo M.
    Saul T.
    Fellmann J.
    McGuire D.
    Cerebrospinal Fluid Research, 3 (1):
  • [6] Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer’s disease and vascular dementia
    Sabrina Ravaglia
    Paola Bini
    Elena Sinforiani
    Diego Franciotta
    Elisabetta Zardini
    Pietro Tosca
    Arrigo Moglia
    Alfredo Costa
    Neurological Sciences, 2008, 29
  • [7] Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia
    Ravaglia, Sabrina
    Bini, Paola
    Sinforiani, Elena
    Franciotta, Diego
    Zardini, Elisabetta
    Tosca, Pietro
    Moglia, Arrigo
    Costa, Alfredo
    NEUROLOGICAL SCIENCES, 2008, 29 (06) : 417 - 423
  • [8] Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression
    Madeira, Caroline
    Vargas-Lopes, Charles
    Brandao, Carlos Otavio
    Reis, Taylor
    Laks, Jerson
    Panizzutti, Rogerio
    Ferreira, Sergio T.
    FRONTIERS IN PSYCHIATRY, 2018, 9
  • [9] Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in patients with Alzheimer's disease
    Targa, Adriano
    Dakterzada, Faride
    Benitez, Ivan
    Lopez, Ricard
    Pujol, Montserrat
    Dalmases, Mireia
    Arias, Alfonso
    Sanchez-de-la-Torre, Manuel
    Zetterberg, Henrik
    Blennow, Kaj
    Pamplona, Reinald
    Jove, Mariona
    Barbe, Ferran
    Pinol-Ripoll, Gerard
    SLEEP, 2021, 44 (02)
  • [10] Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in Alzheimer's disease patients
    Pinol-Ripoll, G.
    Targa, A.
    Benitez, I.
    Dakterzada, F.
    Lopez, R.
    Barbe, F.
    JOURNAL OF SLEEP RESEARCH, 2020, 29 : 21 - 21